Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Phenytoin in acute optic neuritis: neuroprotective or not?
Osmotic demyelination syndrome in Intensive Care Unit.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
BG-12 in Multiple Sclerosis.
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis.
Ultrasonographic diagnosis of demyelinating neuropathy.
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
A prospective study of "undiagnosed" isolated myelopathy: I. Case selection and clinical features.
B-cell depletion in children with neuroimmunologic conditions: The learning curve.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »